Trem-cel and VCAR33 ALLO clinical trial data expected in the second half of 2024 VCAR33 ALLO granted Fast Track and Orphan Drug Designation by U.S. Food & Drug Administration Cash runway extends into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback